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ABSTRACT
Objectives: Despite lumbar degenerative disc disease
(LDDD) being significantly associated with non-specific
low back pain and effective treatment remaining
elusive, specialist multidisciplinary clinical stakeholder
opinion remains unexplored. The present study
examines the views of such experts.
Design: A reliable and valid electronic survey was
designed to establish trends using theoretical
constructs relating to current assessment and
management practices. Clinicians from the Society of
Back Pain Research (SBPR) UK were invited to take
part. Quantitative data were collated and coded using
Bristol Online Surveys (BOS) software, and content
analysis was used to systematically code and
categorise qualitative data.
Setting: Specialist multidisciplinary spinal interest
group in the UK.
Participants: 38/141 clinically active, multidisciplinary
SBPR members with specialist spinal interest
participated. Among them, 84% had >9 years
postgraduate clinical experience.
Interventions: None.
Outcome measures: Frequency distributions were
used to establish general trends in quantitative data.
Qualitative responses were coded and categorised in
relation to each theme and percentage responses were
calculated.
Results: LDDD symptom recurrence, in the absence
of psychosocial influence, was associated with physical
signs of joint stiffness (26%), weakness (17%) and
joint hypermobility (6%), while physical factors (21%)
and the ability to adapt (11%) were postulated as
reasons why some experience pain and others do not.
No one management strategy was supported
exclusively or with consensus. Regarding effective
modalities, there was no significant difference between
allied health professional and medic responses
(p=0.1–0.8). The future of LDDD care was expressed
in terms of improvements in patient communication
(35%), patient education (38%) and treatment
stratification (24%).
Conclusions: Results suggest that multidisciplinary
expert spinal clinicians appear to follow UK-based
assessment guidelines with regard to recurrent LDDD;
there are, however, inconsistencies in the management
approaches supported. This reflects the current
literature and the lack of specific, formalised guidance.
LDDD treatment stratification and further research are
explicitly supported.
INTRODUCTION
Low back pain (LBP) is the top global cause
of years lived with disability.1 The majority of
LBP is classiﬁed as non-speciﬁc LBP
(NSLBP), affecting 30% of the UK popula-
tion annually.2 Over the past 25 years,
research has improved the treatment of
NSLBP through activity promotion, increas-
ing numbers of treatment-focused rando-
mised controlled trials (RCTs) and the
inclusion of a biopsychosocial approach to
therapy.3–5
Strengths and limitations of this study
▪ This study is an online questionnaire survey
designed to explore current perspectives of
degenerative lumbar disc disease from a clinical
spinal specialist interest group (Society of Back
Pain Research, UK).
▪ The survey was designed specifically to explore
current trends with regard to the following theor-
etical constructs: training and education, general
knowledge, assessment and management prac-
tices and future directions.
▪ This study suggests that experienced clinicians
follow an evidence-based approach with regard
to assessment; however, no one management
strategy is supported with consensus, which
reflects the current literature.
▪ Treatment stratification and exploration of the
biological markers are explicitly supported.
▪ Data are from a selected sample of clinically
active, experienced health professionals with a
specialist interest in the spine within the UK,
which limits the generalisability of results.
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However, the results of RCTs focusing on varied treat-
ment approaches for NSLBP are limited by factors such
as sample size, the lack of a control group, the hetero-
geneity of the population under investigation, treatment
ﬁdelity and non-speciﬁc treatment effects, such as
support or empathy of the treatment provider.6 In fact,
to date there seems to be little appreciable beneﬁt, with
current treatments offering small to moderate effects in
terms of a sustained improvement in the quality of life
and disability.7–9
Biopsychosocial approaches have shown a similar
trend. Focus on the psychosocial component through
cognitive–behavioural approaches and functional restor-
ation programmes, while seemingly demonstrating the
potential to reduce National Health Service (NHS) treat-
ment costs,10 have resulted in, at best, moderate treat-
ment effects for patients with NSLBP.11–15 Therefore,
perhaps it is time to recognise the biological component
of the biopsychosocial model in patients with NSLBP,
which may permit effective phenotyping of such indivi-
duals so that speciﬁc stratiﬁed treatment approaches
may be employed to better effect.
Patients with recurrent NSLBP commonly seek care
from multidisciplinary primary and secondary care set-
tings. In order to reduce the ‘fragmentation’ of care,
clinical guidelines are used to standardise management
based on the best available evidence,16 to narrow the
gap between ‘best’ and ‘usual’ practice17 and control for
differences in training, knowledge and scope of the
team of disciplines involved.18 National and inter-
national guidelines have been established to standardise
recurrent NSLBP assessment and management and gen-
erally concur in terms of recommendations relating to
diagnostic triage, assessment, activity promotion and rec-
ognition of psychosocial factors; however, management
discrepancies exist, particularly in terms of exercise pre-
scription, spinal manipulation and patient information.4
These discrepancies may be due to a lack of strong evi-
dence and recommendations based on consensus and
discussion where evidence is lacking.
The recent publication of multidisciplinary guidelines
from the National Institute for Health and Care
Excellence (NICE, UK) reﬂects this.19 The NSLBP man-
agement recommendations within these guidelines are
not explicit and assume unlimited NHS resource: pro-
moting self-management, staying active, education, struc-
tured exercise (up to 8 sessions over up to 12 weeks),
manual therapy including spinal manipulation (9 ses-
sions for up to 12 weeks), acupuncture (for 10 sessions
for up to 12 weeks) and, if improvements are unsatisfac-
tory, referral for combined physical and psychological
treatment (100 hours over 8 weeks).2 19 Although such
multidisciplinary guidelines are justiﬁably limited, given
the available evidence and the current climate of auster-
ity (where, in the UK, the number of treatment sessions
may be restricted to three or four in private or public
healthcare20), perhaps it is time to consider a more spe-
ciﬁc, realistic and practical way forward so that
implementation is possible. Current clinical and patient
opinion reﬂects this need.20 21
In the absence of psychosocial inﬂuence, it remains
challenging to manage recurrent NSLBP symptoms and
to guide effective healthcare provision in this area, with
most clinicians justiﬁably favouring a suboptimal ‘one
size ﬁts all approach’22 in the absence of a suitable alter-
native. However, recent NSLBP research supports a
system of subclassiﬁcation through which targeted treat-
ments have been successfully employed.23 This would
seem to indicate that perhaps a more stratiﬁed and spe-
ciﬁc approach is sensible.
Lumbar degenerative disc disease (LDDD) is a condi-
tion which has been found to be signiﬁcantly associated
(p<0.001) with NSLBP, the lifetime prevalence of which
may be as much as 80% with an annual prevalence rate
of 25–60%.24 LDDD describes a set of signs of disc
degeneration and associated symptoms, namely dis-
ease or pain. Although disc degeneration is often asso-
ciated with LBP,25–27 it is not always synonymous with
LBP, occurring in symptomatic and asymptomatic
populations.28
The presence or absence of pain with LDDD provides
a unique opportunity to examine the differences
between those with LDDD and pain and those without
in order to understand and potentially subclassify this
group according to biological and psychosocial markers.
Although clinicians are one of the primary stake-
holders in patient care, until now, their views have not
been considered with regard to effective LDDD assess-
ment, management and future directions. In order to
advance subclassiﬁcation and treatment stratiﬁcation of
conditions signiﬁcantly associated with NSLBP, it seems
appropriate and timely to gain an appreciation of
current knowledge and practice.
This preliminary exploratory work aims to establish
current trends in opinion from a multidisciplinary spinal
interest group, the Society of Back Pain Research
(SBPR) UK. It is hypothesised that clinicians with such
specialist interest and expertise in the spine will offer a
unique and honest insight into current clinical assess-
ment and management practices, serving to inspire and
inform future work.
METHOD
Participants
The study population was deﬁned as clinically active
members of the SBPR UK from diverse healthcare set-
tings and health professions.
Web survey development and delivery
An electronic survey was designed to establish current
trends with regard to the following theoretical con-
structs: training and education, general knowledge
relating to LDDD and assessment and management
practices. LDDD was deﬁned as lumbar disc degener-
ation with recurrent pain (>3 months duration).
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To ensure that the validity, reliability and respondent
satisfaction were maximised, the questionnaire was
designed to include simple, objective questions with
logical section headers.29–32 To reduce bias secondary to
the error of omission, the response ‘other’ was included
as an option and qualitative comment was invited in
relation to speciﬁc questions to enhance interpretation.
The electronic survey was conducted between 6
February 2014 and 30 May 2014. The survey was distribu-
ted by the SBPR to their specialist interest group
members who were invited to take part (Ethics REC ref-
erence number: 13/LO/0793). Reminders were sent to
non-respondents at 1 and 2 months. A due date was spe-
ciﬁed on invitation. Informed consent was sought from
each participant.
Face and content validity
To ensure that the content of the questionnaire was
meaningful and representative, the survey was developed
following a review of the literature. A pilot study involv-
ing ﬁve independent experts in the spinal ﬁeld (one
professor, one consultant musculoskeletal radiologist,
two advanced physiotherapy spinal practitioners and one
consultant spinal surgeon) was then used to establish
face validity. Following the receipt of feedback, questions
were further modiﬁed to avoid leading questions and to
enhance clarity.
Intrarater reliability
In order to establish intrarater reliability, 10 chartered
physiotherapists with advanced musculoskeletal knowl-
edge were invited to complete the survey at weeks 1
and 3.
To ensure that the results were consistent, quantitative
responses for weeks 1 and 3 were coded using the
Bristol online survey tool and analysed to determine
intrarater reliability using IBM SPSS Statistics Software
V.22 (IBM, Armonk, New York, USA). Intrarater reliabil-
ity in this instance was deemed to be substantial (using
Landis and Koch deﬁnition,33 κ=0.6).
Data analysis
Descriptive statistics involving frequency distributions
were used to establish general trends in opinion.
Quantitative data were coded as described above. Mann
Whitney U tests for non parametric data (two tailed)
were used to establish signiﬁcant differences between
medical professions with regard to LDDD assessment
and management conﬁdence and LDDD treatment
scores. Normality was evaluated using histograms and
the Shapiro Wilks test. A result was considered statistic-
ally signiﬁcant at the 5% level (p≤0.05).
Content analysis was used to objectively and systematic-
ally categorise and quantify qualitative data in order to
permit successful analysis.34 Using an inductive
approach, all qualitative responses were read to gain an
appreciation of content and context. The recommended
organisational phases of coding, grouping,
categorisation and abstraction were then employed35 to
condense qualitative information. To control for the sub-
jective and interpretative process, three health profes-
sionals with expertise in the area were invited to review
all meaning units, codes, subthemes and themes in con-
junction with qualitative responses. Following discussion
and reﬂection, minor amendments were necessary to
exclude responses that were deemed ‘too general to
code’. Decisions were made by consensus.
RESULTS
Response rate and demographics
All quantitative and qualitative responses (response rate
38/141, 27%) were collated and analysed using Bristol
Online Surveys (BOS) software (University of Bristol).
Respondents were SBPR members (87% of respondents
graduated within the UK), clinically active and repre-
sented a variety of clinical backgrounds (nursing (n=1),
rheumatology (n=1), physiotherapy (n=22), surgery
(n=10) and general practice (n=4)). The majority had
>9 years of postgraduate clinical experience (84%)
(table 1).
LDDD: definition, prevalence, signs and causes
Most clinicians (37%) reported a high LDDD preva-
lence (50% or more) from their clinical experience of
working in primary and secondary care settings. The
primary causal factors for LDDD were cited as genetics
(33%), posture (15%) and movement patterns (18%)
(smoking, age, obesity, occupation and previous trauma
were also referenced).
Clinicians deﬁned the signs and symptoms associated
with LDDD as being dependent on whether the condi-
tion was acute (<3 months duration) or a long-standing,
recurrent presentation (>3 months duration); reporting
pain as the dominant symptom in long-standing degen-
erative (30%) scenarios. The clinical signs reported to
most likely result in recurrence included joint stiffness
(26%), weakness (17%) and joint hypermobility (6%)
(table 1).
LDDD assessment and management
Of the total respondents, 47–50% reported conﬁdence
levels of eight or over with regard to LDDD assessment
and management (where 0/10 represented no conﬁ-
dence and 10/10 representing extreme conﬁdence). No
signiﬁcant difference in clinical conﬁdence rating was
found between allied health professionals (AHPs) and
medics (p=0.8–0.9; table 2).
The majority of respondents considered MRI (95%)
and physical assessment (55%) to be the most important
clinical tools when conﬁrming a diagnosis of LDDD.
Respondents considered a reduction of disc height
(92%) and disc dehydration (90%) as the most import-
ant variables when diagnosing LDDD (table 1).
In terms of grading LDDD on MRI, 47% of respon-
dents use the Modic classiﬁcation system clinically to
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Table 1 Respondent interpretations of themes relating to training and education, LDDD definition, impact and future
management
Themes Items Descriptors Responses (n) Response rate (%)
Training and
education
Years of postgraduate
experience
0–2 years 1 2.6
3–5 years 0 0
6–8 years 5 13.2
9+ years 32 84.2
Country of graduation UK 33 86.8
Other 5 13.2
Definition of
LDDD
Definition of LDDD Dehydrated disc 17 44.7
Change in disc integrity 26 68.4
Intervertebral changes 7 18.4
Disc height reduction 7 18.4
Symptomatic 13 34.2
Asymptomatic 4 28.9
Multifactorial causes 19 50.0
Do not use this term 2 5.3
Not a disease 7 18.4
LDDD prevalence in clinic 0–10% 5 13.2
10–30% 9 23.7
30–50% 5 13.2
50% + 14 36.8
Unsure 1 2.6
Not applicable 4 10.5
LDDD cause Genetics 13 33
Posture 6 15
Movement patterns 7 18
Smoking 9 23
Unsure 2 4
Other (comorbidities) 8 21
Signs associated with
LDDD
Weakness 6 17
Joint hypermobility 2 6
Joint stiffness 10 26
Pain 11 30
Paraesthesia 5 14
Unsure 2 4
Other (stenosis, spondylolisthesis,
reduced lordosis)
4 10
LDDD
assessment
Confirmation of diagnosis MRI 36 94.7
Physical assessment 21 55.3
None of the above 0 0
Other (medical history) 17 44.7
MRI findings are
associated with LDDD
Osteophytes 25 65.8
Annular tear 28 73.7
Disc bulges 32 84.2
Disc herniations 28 73.7
Reduction in disc height 35 92.1
Evidence of disc dehydration 34 90
Unsure 1 2.6
Other (Modic or end plate changes) 12 31.6
Classification system used
for grading LDDD
Modic grading system 18 47.4
Pfirrmann grading system 9 23
Modified Pfirrmann grading 2 5.3
None of the above 10 26.3
Other (do not use classification
systems)
7 18.4
Why degenerative change
is often not proportional to
presenting symptoms
Pyschosocial factors 9 23
Pain perception/interpretation 5 13
Pain mechanisms 6 16
Physical factors 8 21
Continued
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Table 1 Continued
Themes Items Descriptors Responses (n) Response rate (%)
Ability to adapt 4 11
Infection 1 3
Genetics 1 3
Don’t know 6 16
DLDD is not the cause 3 8
Use of functional tests as
part of assessment
Yes 34 89.5
No 4 10.5
Most effective functional
tests used in LDDD
assessment
Gait 19 50
Double leg stand (eyes open and eyes
shut)
6 15.8
Single leg stand (eyes open and eyes
shut)
8 21.1
Double leg squat 5 13.2
Single leg squat 6 15.8
Lunge 3 7.9
Sit to stand 14 36.8
All of the above 4 10.5
None of the above 5 13.2
Other (repeated movement and range
of movement)
13 34.2
Muscles most commonly
affected
Calf 1 2.6
Ankle dorsiflexors 1 2.6
Quads 1 2.6
Hamstrings 1 2.6
Gluteus medius 4 10.5
Gluteus maximus 4 10.5
Extensors 10 26.3
Erector spinae 10 26.3
Multifidus 15 39.5
Abdominals 4 10.5
TVA 7 18.4
Psoas 1 2.6
Quadratus lumborum 2 5.3
Lat dorsi 1 2.6
Unsure 5 13.2
LDDD impact
and future
Impact of LDDD with
recurrent pain on quality of
life
Serious 6 15.8
Significant 22 57.9
Minimal 2 5.3
None 0 0
Unsure 8 21.1
Impact of psychosocial
factors on LDDD and
recurrent pain
Serious 8 21.1
Significant 25 65.8
Minimal 1 2.6
None 0 0
Unsure 4 10.5
Future improvements in
care
Inclusive communication 13 35.1
Stratified treatment 9 24.3
Effective patient education 14 37.8
Encourage self-management 4 10.8
Realistic goals and expectations 3 8.1
Evidence-based management 9 24.3
Consideration of long term 1 2.7
Holistic approach 3 8.1
Early intervention and service access 5 13.5
Specific diagnosis 1 2.7
MDT approach 2 5.4
LDDD, lumbar degenerative disc disease; MDT, multidisciplinary team; TVA, transversus abdominus.
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grade degenerative end plate or Modic changes, which
are signiﬁcantly associated with LDDD, while 23% and
5% used disc-speciﬁc grading tools such as the
Pﬁrrmann and the modiﬁed Pﬁrrmann grading tools,
respectively.
Ninety per cent of respondents use functional move-
ments as part of routine assessment, of which the most
commonly assessed movements include gait (50%), sit
to stand (37%), double leg standing (eyes open and
shut) (16%) and single leg standing (eyes open and
shut) (21%) with muscles most commonly affected by
the condition reported to include the erector spinae
(26%) and multiﬁdus (40%) and to a lesser degree the
abdominals and gluteals. Only one respondent cited
thigh or shank muscle involvement.
In terms of recurrent, long-standing effective LDDD
management, there was no signiﬁcant difference
between AHP and medic responses (p=0.1–0.8; table 2).
Education and reassurance, pain management, cogni-
tive–behavioural therapy, core stability training and
group approaches to treatment were reported to be the
most effective (ﬁgure 1) with Pilates, yoga, pain manage-
ment and back to ﬁtness programmes being favoured
over a hands-on approach. Although signiﬁcant differ-
ences in mean scores were noted between AHP and
medics in relation to manual therapy (p=0.02) and elec-
trotherapy (p=0.03), the mean scores reﬂect AHP and
medic interpretations that electrotherapy and manual
therapy are ‘not very effective’ or ‘ineffective’, respect-
ively (table 2). This difference may represent a profes-
sional bias in terms of the profession-speciﬁc treatments
each employ; however, scores indicate that both groups
interpret such modalities to be suboptimal.
Recurrence was also reported to signiﬁcantly affect
quality of life (58%), with psychosocial factors (66%) sig-
niﬁcantly inﬂuencing LDDD symptom recurrence.
Qualitative data
Respondents were asked to deﬁne LDDD to establish
the meaning they attributed to this term. The majority
Table 2 AHP and medic mean clinical confidence and LDDD treatment efficacy scores
Themes AHP mean scores (SD) Medic mean scores (SD) p Value
Confidence (where 0 is not confident and 10 is confident)
Assessment confidence 7.2 (2.2) 5.5 (1.5) 0.8
Management confidence 7.2 (2.4) 7 (1.5) 0.9
Treatment efficacy (where 3 is effective and 1 is ineffective)
Education and reassurance 2.9 (0.6) 2.8 (0.4) 0.2
Acupuncture 1.3 (0.9) 1.5 (0.7) 0.8
Core stability training 2.7 (0.5) 2.2 (0.5) 0.1
Manual therapy 2.3 (0.5) 1.6 (0.8) 0.02*
Cognitive–behavioural approach 2.6 (0.4) 2.4 (0.4) 0.4
Pain management 2.5 (0.5) 2.3 (0.6) 0.2
Electrotherapy 1.5 (0.6) 0.7 (0.3) 0.03
Surgery 1.5 (0.7) 2.1 (0.7) 0.2
Classes/groups 2.3 (0.5) 2.4 (0.6) 0.8
*Statistical significance at the 5% level (p≤0.05).
AHP, allied health professionals; LDDD, lumbar degenerative disc disease.
Figure 1 The modalities which respondents cite as the most effective for managing LDDD. LDDD, lumbar degenerative disc
disease.
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deﬁned this condition in terms of disc dehydration
(45%) with concomitant changes in disc height (19%),
disc integrity (68%) and the vertebrae (18%). Forty-ﬁve
per cent of respondents also referred to an associated
presence (34%) and/or absence (11%) of symptoms.
The multifactorial nature of the condition (with refer-
ence to ageing, environmental and genetic inﬂuences)
was reported by 50% of respondents. Interestingly, 18%
of respondents did not feel that the diagnostic term
LDDD is useful as it is ‘not a disease’, with 5% reporting
that they therefore do not use the term.
The current understanding relating to the apparent
mismatch between the degree of pain patients may or
may not experience and MRI indicators of lumbar disc
degeneration was also explored. In the absence of psy-
chosocial inﬂuence, this phenomenon was explained by
physical factors (21%, including movement dysfunction,
muscle activation and strength) and the ability to physic-
ally adapt (11%; ﬁgure 2). Psychosocial factors (23%),
pain perceptions and interpretations (13%) and the
complexity of pain mechanisms (16%) were also
reported. Sixteen per cent did not understand why this
phenomenon occurs, with 8% of respondents believing
LDDD is not causal, implying that it may result from
pain.
The future management of recurrent and long-
standing LDDD was seen by the majority of respondents
in terms of inclusive communication (35%) and patient
education (38%; ﬁgure 3). The concept of treatment
stratiﬁcation (24%) and the emphasis placed upon
advancing evidence-based management practices (24%)
through research were recommended. This question was
unanswered by one respondent and the missing
response was not replaced by imputed values.
DISCUSSION
This exploratory study presents novel data; for the ﬁrst
time, the frank opinions of multidisciplinary clinicians
have been explored, with responses that are based on
clinical experience, thereby representing clinical prac-
tice. In the absence of deﬁnitive answers with regard to
LDDD assessment and management of recurrent symp-
toms, clinical decisions have to be made. The results
from our study represent an evidence-informed
approach, where a wealth of clinical experience and
insight is presented in conjunction with the current evi-
dence and practice.
LDDD assessment
As a result of our exploratory work, it is clear that the
results obtained reﬂect the views of experienced and
knowledgeable clinicians, in that the majority of respon-
dents reported a high level of LDDD assessment and
management conﬁdence and attributed the same
meaning to the condition, in terms of deﬁnition, as the
authors did. This was further enhanced through reliabil-
ity and validity testing of the survey prior to distribution.
It is of interest that when clinicians were asked how
they deﬁne LDDD, 18% cited that they do not make use
of the term LDDD: ‘I do not consider it to be a disease’,
with 5% responding that they simply did not use the
term. There were also repeated themes referenced in
relation to diagnosis; on the one hand, respondents pro-
posed avoiding labelling; ‘stop interfering and making
life worse…avoid labeling’, while, on the other, a more
speciﬁc diagnosis than NSLBP was requested: ‘I think we
need to give patients a diagnosis that is more speciﬁc
than NSLBP’. While as a set of signs and symptoms, the
term LDDD seems representative and encompassing, for
the clinician, it seems a limited term; having potential to
engender fear, while alternatives such as NSLBP fail to
offer reassurance to patients who fear judgement and
stigmatisation from this generic, ‘non’-label.21 36 Clearly
further clariﬁcation and guidance is required.
SBPR clinicians agreed that LDDD is highly prevalent
(50% or more), which is reﬂective of the environments
in which clinicians with specialist spinal interest work.
However, reported prevalent rates vary within the litera-
ture as assessment gold standards are lacking and
Figure 2 Respondent interpretations of why the degree of degenerative change associated with LDDD is often not proportional
to the presenting symptoms. LDDD, lumbar degenerative disc disease.
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population deﬁnitions remain inconsistent. Estimates
therefore range between 40% and 90% in symptom-
atic26 and 10–80% in asymptomatic populations.37
The gold standard for assessment of structural disc
degeneration is MRI.38 In order to classify disc degener-
ation, several reliable and discriminatory methods are
reported, including the Pﬁrrmann and the modiﬁed
Pﬁrrmann grading systems. Modic or vertebral end plate
changes39 are also commonly used by radiologists due to
their signiﬁcant association with NSLBP40 and signiﬁ-
cant correlation with degenerative disc grading
(Pﬁrrmann and modiﬁed Pﬁrrmann grades (p<0.01)).41
In the current study, clinicians recognise MRI as the
assessment gold standard, with the majority favouring
Modic classiﬁcation and to a lesser degree Pﬁrrmann
classiﬁcation systems. This is not surprising as the Modic
system is easy to apply, score and shows a high degree of
association with degenerative change unlike the
Pﬁrrmann system, which relies on multiple gradings,
descriptors and images.
The reported causal factors cited by clinicians concur
with the literature and it is evident that, from a clinical
viewpoint, the effect of posture and movement patterns
should not be underestimated and that weakness, joint
stiffness and hypermobility may all play a part in the
recurrence and longevity of LDDD symptoms. Indeed,
in the section of the questionnaire that referred to phys-
ical assessment, clinicians regarded functional physical
assessment as key; the majority tending to assess move-
ments typically associated with the exacerbation of symp-
toms and which are, therefore, more meaningful to
patients (eg, gait or sit to stand). However, it is interest-
ing that clinicians do not standardly consider the inﬂu-
ence of the whole kinematic chain (ie, spine, pelvis and
lower limb) in terms of its contribution towards recur-
rence, focusing on speciﬁc muscles such as the erector
spinae and transversus abdominus. If clinical emphasis is
to successfully change from psychosocial to biopsychoso-
cial, in order to effectively stratify treatment, we need to
avoid narrowing our hypothesis too early and consider
the global biological chain of contributing factors.
In the assessment section, clinicians were asked why
they felt LDDD symptoms were often not found to be
proportional to the degree of degeneration evident on
MRI. While responses emphasised psychosocial factors
and the complexity of pain mechanisms, biological
factors such as movement dysfunction, movement strat-
egy and the ability to physically adapt were also sup-
ported. However, interestingly 16% of clinicians did not
feel that they were equipped with the answers to this
question, implying that there is a lot we do not know;
‘the reason is not completely clear’.
LDDD management
Our results suggest that current specialist practice sup-
ports a multimodal, generic approach, which falls in line
with current NICE guidelines: promoting self-
management, staying active, education, structured exer-
cise, manual therapy including spinal manipulation or
referral for combined physical and psychological treat-
ment.2 From our research, it would seem that no one
strategy is supported exclusively or with consensus.
Indeed, from the qualitative responses received, there
seems to be confusion regarding the speciﬁcs of best
practice especially in terms of exercise. Although the
authors do not advocate completely deﬁning practice, as
clinicians require autonomy in order to be able to make
the best clinical judgments, management guidelines
Figure 3 The variety of ways in which respondents believe LDDD management can be improved in the future. LDDD, lumbar
degenerative disc disease.
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which recommend ‘manual therapy’ for nine sessions
for up to 12 weeks or ‘structured exercise’ for eight ses-
sions for up to 12 weeks become meaningless to the
NHS clinician who is guided to implement a therapy
that has not been deﬁned and is unable to fulﬁl the
brief due the cost incurred. Therefore, redeﬁning guid-
ance in order to reﬂect current practice will be neces-
sary moving forward in order to ensure successful
implementation and improve patient outcomes.
Over the years RCTs have focused on an inﬁnite
number of intervention combinations, the way treatment
is delivered and the cost implications.10 42–50 The NICE
guidelines2 19 outline the best evidence resulting from
such trials and the current practice of SBPR clinicians
reﬂects this approach. However, the effect sizes in these
trials are at best small to moderate,9 implying that we
have not found an acceptable solution.
There is no doubt that over the past 25 years, recogni-
tion of the psychosocial has improved practice.5 Indeed,
respondents in this study continue to view the contribu-
tion of psychosocial factors as having a signiﬁcant
impact on LDDD symptom recurrence (66%). However,
in spite of this, treatments that focus on the psychosocial
have been found to have moderate effects.11 13–15 In
fact, patients with NSLBP have not been found to have
signiﬁcantly higher psychosocial comorbidity than the
average patient consulting primary care.15
Therefore, it would seem that the ‘back pain revolu-
tion’,51 which has seemingly absolved clinicians of
responsibility (patients with yellow ﬂags or psychosocial
factors being referred for group intervention)52 and has
given the NHS an opportunity to deal with NSLBP in a
more ‘cost-effective’ manner, cannot deliver effectively if
the clinical over-reliance on the psychosocial continues.
Although classes and group treatments may have their
place, the future management of recurrent and long-
standing LDDD was seen by the majority of SBPR
respondents not only in terms of inclusive communica-
tion and patient education but also in terms of treat-
ment stratiﬁcation and advancing evidence-based
management practices.
In relation to communication and patient education,
the support of clear, open, honest, collaborative, deme-
dicalised communication in our study is nothing new.
However, it is of interest that clinicians feel that this area
remains a cause for concern. Given current evidence
and guidance, it is possible that being honest is difﬁcult;
if one is not guided as to how to best treat, perhaps one
is forced to opt for treatment modalities which are, at
best, mildly to moderately effective.
The continuation of realistic goal and expectation
setting, multidisciplinary support and self-management
promotion is supported. However, there is also support
for early and prophylactic treatment: ‘Press for greater
allocation of resources to treat patients earlier in the
process’, and consideration of the long term: ‘advise
and support patients in the long term and review them
regularly as opposed to discharging them if immediate
results are not obtained’. Advancing the clinical evi-
dence base in the area of management and stratiﬁcation
of treatment were also cited as ways of improving the
future of care: ‘is there a modality that is best for the
patients and can we sub-classify these patients to ensure
they are getting the best care?’, ‘we need to offer speciﬁc
treatment’, ‘set realistic not blinkered system approach
to exercise’. This area clearly requires investigation.
The requirement for specialist spinal knowledge and
experience from clinically active health professionals, is
a strength in this study. The response rate of 27% for
this exploratory work is over double the average cited
for web surveys (11%);53 however, due to the speciﬁc
inclusion criteria employed and limited accessibility to
groups of such speciﬁc clinical interest in the UK, it is
recognised that the sample size limits the generalisability
of the results. Assumptions made regarding honesty and
accuracy of responses, potential non-response bias and
convenience sampling, which affect most studies of this
nature, may also be regarded as limitations.
CONCLUSIONS
This survey provides novel information relating to
LDDD and the perspectives of multidisciplinary clini-
cians in the UK with a specialist spinal interest.
Although the aim of this study is not to make deﬁnitive
recommendations, it seems reasonable to acknowledge
the experienced multidisciplinary voice, whose daily
work in environments requires decisions to be made in
the absence of certainty or guidelines that provide the
deﬁnitive answer. Regarding how we as health profes-
sionals may seek to improve the future of management
of this condition, there is a clear message; transparent
patient communication is required as there is a lot we
have yet to understand. Expert clinicians are also keen
to allocate resources to treat patients earlier in the
process and to review patients regularly without deﬁned
discharge so that patients are empowered to self-manage
without fear of being abandoned by the system. Finally,
there is a commitment to tailored, evidence-based man-
agement, to suit the individual on a holistic level.
Moving forward, the challenge will be to develop
deﬁned clinical subgroups for which effective interven-
tion is possible.
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